Navigation Links
Yew Bio-Pharm Group Announces Coverage by S&P Capital IQ
Date:8/23/2013

HARBIN, China, Aug. 23, 2013 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine and products made from yew timber in China, today announced that S&P Capital IQ has commenced coverage on Yew Bio-Pharm Group. A copy of the nine-page report, which includes an operational review, business summary, financial information, management biographies, and a sub-industry outlook, can be downloaded here: http://www.yewchina.com/En/Article.asp?ColumnId=5&NewsTypeId=11.

"We are pleased to receive professional coverage from such a well-respected company as Standard & Poor's," commented Mr. Zhiguo Wang, Chairman and Chief Executive Officer of Yew Bio. "We hope that this coverage will be helpful to our current and future investors in understanding and tracking the progress of Yew Bio."

ABOUT S&P CAPITAL IQ

S&P Capital IQ, a part of McGraw Hill Financial, is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. Evaluated pricing is prepared by Standard & Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission. In the United States, research reports are prepared by Standard & Poor's Investment Advisory Services LLC, a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission. S&P Capital IQ provides a broad suite of capabilities designed to help track performance, generate alpha, and identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as the S&P Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Capital IQ Valuations; and research offerings, including Leveraged Commentary & Data, Global Markets Intelligence, and company and funds research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need. For more information visit: www.spcapitaliq.com.

ABOUT YEW BIO-PHARM GROUP, INC

Yew Bio-Pharm Group, Inc., through its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber in China. Raw material from the species of yew tree that the Company grows contains taxol, and TCM containing yew raw materials has been approved as a traditional Chinese medicine in China for secondary treatment of certain cancers. The Company uses a patented, accelerated growth technology to speed the growth and maturity and commercialization of yew trees and believes that it is one of the few companies possessing a permit to sell them.

Company Contacts:

Yew Bio-Pharm Group, Inc.

Ms. Sha Jin

Tel: (702) 487-4683

E-mail: hdsusasj@gmail.com

Investor Relations Contacts:

CCG Investor Relations

Mr. John Harmon, CFA, Sr. Account Manager

Tel: +86 (10) 8573 1014 (Beijing)

E-mail: john.harmon@ccgir.com


'/>"/>
SOURCE Yew Bio-Pharm Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Educating, Informing, and Successfully Preparing the Marketplace for New Bio-Pharma Products
2. Bio-pharma Internal Communications Groups Evolving for Structure Optimization
3. Yew Bio-Pharm Group Announces Second-Quarter 2013 Results
4. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Watson to Acquire Actavis Group for EUR4.25 Billion
7. CentraState and Freehold Radiology Group train physicians from China
8. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
9. Okuma America Chooses The Daniel Group To Provide Customer Service Research
10. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
11. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Maine and SCOTTSDALE, Ariz. , ... Health Information Exchange (HIE), announced today it is ... medicine platform. HealthInfoNet,s HIE contains 98% of all ... all Maine hospitals and over 500 ... Board of Directors, HealthInfoNet plans to deploy Orion Health,s ...
(Date:2/16/2017)... LONDON , February 16, 2017 ... die Verbesserung der Wettbewerbsfähigkeit haben in der Medizinproduktebranche ... richtet die globale Medizinproduktebranche den Blick auf unmittelbar ... die bevorstehende Implementierung in diesen Regionen. ... ...
(Date:2/16/2017)... , Feb. 16, 2017 OTTO Health LLC ... of Product Evan Frankel will speak at the ... on Feb. 19–23, 2017 in Orlando, Fla. ... Use Telehealth as a Tool for Network Management " during ... The 2017 HIMSS Annual Conference & Exhibition brings together ...
Breaking Medicine Technology:
(Date:2/17/2017)... , ... February 17, 2017 , ... ... Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' 2017 "Staffing ... 100 honors those who have made notable contributions to the staffing industry over ...
(Date:2/17/2017)... CO (PRWEB) , ... February 17, 2017 , ... Top ... annual International Healing NET Foundation Summit from February 21 - 23 in Beaver Creek, ... Foundation (HNF). This marks the Summit’s second year in Beaver Creek, hosting over 60 ...
(Date:2/16/2017)... New York, New York (PRWEB) , ... February ... ... hard work and determination. After what took over 10 years of research, development ... disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ...
(Date:2/16/2017)... , ... February 17, 2017 , ... ... and financial planning services to families and entrepreneurs in the Birmingham area, is ... adoptive mother who needs assistance with her medically challenged son, Anius. , Anius ...
(Date:2/16/2017)... ... 2017 , ... PRESS RELEASE, FOR IMMEDIATE RELEASE:, CONTACT:, David ... Doege is excited to announce the launch of Doege Development, LLC, a Phoenix-based ... build, and site improvements. , Mr. Doege says, "I am so excited to ...
Breaking Medicine News(10 mins):